Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
Steven C. Katz(Boston University), Richard P. Junghans(Boston University), Lauren A. Licata(Roger Williams Medical Center), Cang T. Nguyen(Roger Williams Medical Center), Rachel A. Burga(Barricaid (United States)), Doreen Osgood(Roger Williams Medical Center), Jonathan A. Fletcher(Harvard University), N. Joseph Espat(Roger Williams Medical Center), Mitchell Thorn(Providence College), Seema Naheed(Boston University)
Cited by 26
Related Papers
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
|Oncogene|2001|700
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2000|647
Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma
|American Journal Of Pathology|2001|639